Protein Phosphatase-2A associates with the cytoskeleton to maintain cell spreading and reduced motility of nonmetastatic Lewis lung carcinoma cells: The loss of this regulatory control in metastatic cells

Invasion and Metastasis

Volumn 17, Issue 4, 1998, Pages 199-209

  Jackson, Jodi ^b   Meisinger, Jeremy ^a   Patel, Snehal ^a   Lim, Zenia C ^a   Vellody, Kishore ^b   Metz, Raymond ^b   Young, M Rita I ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Cancer; Cytoskeleton; Lewis lung carcinoma; Metastasis; Microtubules; PP 2A; Protein phosphatase 2; Tumor

Indexed keywords

LAMININ; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; TUBULIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL INVASION; CELL MOTILITY; CELL SPREADING; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; ENZYME SUBUNIT; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEWIS CARCINOMA; METASTASIS; MICROTUBULE; MOUSE; NONHUMAN;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL MOVEMENT; CYTOSKELETON; MICROTUBULES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHOPROTEIN PHOSPHATASE;

EID: 0345267245     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bernstein LR, Liotta LA: Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol 1994;6:106-113.
2. You J, Miele ME, Dong C, Welch DR: Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion. Biochem Biophys Res Commun 1995;208: 476-484.
3. Veatch AL, Carson LF, Ramakrishnan S: Phenotypic variations and differential migration of NIH: OVCAR-3 ovarian carcinoma cells isolated from athymic mice. Clin Exp Metastasis 1995;13:165-172.
4. Nabi IR, Watanabe H, Raz A: Autocrine motility factor and its receptor. Role in cell locomotion and metastasis. Cancer Metastasis Rev 1992;11:5-20.
5. Shimokawa-Kuroki R, Sadano H, Taniguchi S: A variant actin (beta m) reduces metastasis of mouse B16 melanoma. Int J Cancer 1994;56: 689-697.
6. Sadano H, Shimokawa-Kuroki R, Taniguchi S: Intracellular localization and biochemical function of variant beta-actin, which inhibits metastasis of B16 melanoma. Jpn J Cancer Res 1994;85:735-743.
7. Lakshmi MS, Parker C, Sherbet GV: Metastasis and associated MTS1 and NM23 genes affect tubulin polymerization in B16 melanomas: A possible mechanism of their regulation of metastatic behaviour of tumours. Anticancer Res 1993; 13: 299-303.
8. Button E, Shapland C, Lawson D: Actin, its associated proteins and metastasis. Cell Motil Cytoskeleton 1995;30:247-251.
9. Imai K, Kumagai S, Nakagawa K, Yamamoto E, Nakanishi I, Okada Y: Immunolocalization of desmoglein and intermediate filaments in human oral squamous cell carcinomas. Head Neck 1995;17:204-212.
10. Young MRI, Lozano Y, Djordjevic A, Maier D: Protein phosphatases limit tumor motility. Int J Cancer 1993;54:1036-1041.
11. Young MRI, Charboneau S, Lozano Y, Djordjevic A, Young ME: Activation of the protein kinase A signal transduction pathway by granulocyte-macrophage colony-stimulating factor or by genetic manipulation reduces cytoskeletal organization in Lewis lung carcinoma variants. Int J Cancer 1994;54:446-451.
12. Maier GD, Wright MA, Lozano Y, Djordjevic A, Matthews JP, Young MRI: Regulation of cytoskeletal organization in tumor cells by protein phosphatases-1 and -2A. Int J Cancer 1995:61:51-54.
13. Gurland G, Gundersen GG: Protein phosphatase inhibitors induce the selective breakdown of stable microtubules in fibroblasts and epithelial cells. Proc Natl Acad Sci USA 1993; 90:8827-8831.
14. Shinoki N, Sakon M, Kambayashi J, Ikeda M, Oiki E, Okuyama M, Fujitani K, Yano Y, Kawasaki T, Monden M: Involvement of protein phosphatase-1 in cytoskeletal organization of cultured endothelial cells. J Cell Biochem 1995;59:368-375.
15. Law B, Rossie S: The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2-ceramide. J Biol Chem 1995;270:12808-12813.
16. Cohen P: Classification of protein-serine/threonine phosphatases: Identification and quantitation in cell extracts. Methods Enzymol 1991;201:389-427.
17. Sontag E, Nunbhakdi-Craig V, Bloom GS, Mumby MC: A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J Cell Biol 1995;128:1131-1144.
18. Gutierrez LM, Quintanar JL, Rueda J, Viniegra S, Reig JA: The protein phosphatase inhibitor calyculin-A affects catecholamine secretion and granular distribution in cultured adrenomedullary chromaffin cells. Eur J Cell Biol 1995;68:88-95.
19. Yano Y, Sakon M, Kambayashi J, Kawasaki T, Senda T, Tanaka K, Yamada F, Shibata N: Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2A inhibitors okadaic acid and calyculin A. Biochem J 1995;307:439-449.
20. Young MRI, Young ME, Lozano Y, Coogan M, Bagash JM: Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones. Int J Cancer 1991;49:150-155.
21. Metz R, Vellody K, Patel S, Bergstrom R, Meisinger J, Wright MA, Lozano Y, Young MRI: Elevation of protein phosphatase-2A reduces tumor cell migration through extracellular matrix components. Invasion Metastasis, in press.
22. Favre B, Zolnierowicz S, Turowski P, Hemmings BA: The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. J Biol Chem 1994;269:16311-16317.
23. Silletti S, Paku S, Raz A: Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells. Am J Pathol 1996;148:1649-1660.
24. Verschueren H, Van der Taelen I, Dewit J, De Braekeleer J, De Baetselier P: Metastatic competence of BW5147 T-lymphoma cell line is correlated with in vitro invasiveness, motility and F-actin content. J Leukocyte Biol 1994;55:552-556.
25. Giese A, Rief MD, Loo MA, Berens ME: Determinants of human astrocytoma migration. Cancer Res 1994;54:3897-3904.
26. Pokoma E, Jordan PW, O'Neill CH, Zicha D, Gilbert CS, Vesely P: Actin cytoskeleton and motility in rat sarcoma cell populations with different metastatic potential. Cell Motili Cytoskeleton 1994;28:25-33.
27. Stracke ML, Soroush M, Liotta LA, Schiffmann E: Cytoskeletal agents inhibit motility and adherence of human tumor cells. Kidney Int 1993;43:151-157.
28. Trachsel S, Keller HU: Selective responses (actin polymerization, shape changes, locomotion, pinocytosis) to the PKC inhibitor Ro 31-8220 suggest that PKC discriminately regulates functions of human blood lymphocytes. J Leukocyte Biol 1995;57:587-591.
29. Huang TJ, Lee TT, Lee WC, Lai YK, Yu JS, Yang SD: Autophosphorylation-dependent protein kinase phosphorylates Ser25, Ser38, Ser65, Ser71, and Ser411 in vimentin and thereby inhibits cytoskeletal intermediate filament assembly. J Protein Chem 1994;13:517-525.
30. 3 coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization. Clin Exp Metastasis 1997; 15:102-110.
31. Scott G, Liang H: pp125FAK in human melanocytes and melanoma: Expression and phosphorylation. Exp Cell Res 1995;219:197-203.